FIELD: medicine.
SUBSTANCE: pharmaceutical compositions include divalent, namely calcium, magnesium or zinc salt, of pravastatin or fluvastatin and omega-3 fat, for prevention, reduction or treatment of increased cholesterol levels, atherosclerosis, hyperlipidemia, cardio-vascular disorders and diseases, coronary heart disease and/or cerebrovascular disease.
EFFECT: improved bioavailability of compositions, easily obtained and introduced.
40 cl, 33 dwg, 2 tbl, 8 ex
Authors
Dates
2010-02-27—Published
2005-08-05—Filed